Study investigates how effective multiple sclerosis medications are across racial and ethnic groups

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainFor people with relapsing-remitting multiple sclerosis (MS), a new study has found that the drug ofatumumab is more effective tha

Updated on: July 31,2024

Study investigates how effective multiple sclerosis medications are across racial and ethnic groups

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainFor people with relapsing-remitting multiple sclerosis (MS), a new study has found that the drug ofatumumab is more effective tha

Updated on:July 31,2024

When memory loss should concern you

by Lauren Woods,University of ConnecticutCredit: AI-generated imageAlthough there is currently no cure for Alzheimer's Disease, Dr. Patrick Coll of UConn's Center on Aging recommends ear

Updated on: February 27,2024

When memory loss should concern you

by Lauren Woods,University of ConnecticutCredit: AI-generated imageAlthough there is currently no cure for Alzheimer's Disease, Dr. Patrick Coll of UConn's Center on Aging recommends ear

Updated on:February 27,2024

Alzheimer's risk gene impairs development of new neurons in mice

by Society for NeuroscienceApoE-expressing astrocytes (green) interacting with tdTomato-expressing dendrites (red) from adult newborn hippocampal neurons. Credit: Tensaouti et al.,eNeuro&nb

Updated on: April 20,2024

Alzheimer's risk gene impairs development of new neurons in mice

by Society for NeuroscienceApoE-expressing astrocytes (green) interacting with tdTomato-expressing dendrites (red) from adult newborn hippocampal neurons. Credit: Tensaouti et al.,eNeuro&nb

Updated on:April 20,2024

People with Alzheimer's have worse outcomes after an emergency revascularization

by University of Eastern FinlandCredit: Pixabay/CC0 Public DomainThe risk of both mortality and rehospitalization after an elective revascularization procedure for coronary artery disease is simi

Updated on: April 20,2024

People with Alzheimer's have worse outcomes after an emergency revascularization

by University of Eastern FinlandCredit: Pixabay/CC0 Public DomainThe risk of both mortality and rehospitalization after an elective revascularization procedure for coronary artery disease is simi

Updated on:April 20,2024

Alzheimer's disease can be diagnosed before symptoms emerge

by Lund UniversityNIA-AA versus IWG criteria. Differences in the nomenclature of cognitively unimpaired individuals with (+) or without (−) in vivo biomarker evidence of Aβ (A) and tau (T) pathol

Updated on: April 10,2024

Alzheimer's disease can be diagnosed before symptoms emerge

by Lund UniversityNIA-AA versus IWG criteria. Differences in the nomenclature of cognitively unimpaired individuals with (+) or without (−) in vivo biomarker evidence of Aβ (A) and tau (T) pathol

Updated on:April 10,2024

Alzheimer's research—intracellular calcium store malfunction leads to brain hyperactivity

by Universitaet TübingenAmyloid proteins (plaques, blue) in the cerebral cortex of a mouse model of Alzheimer’s disease, surrounded by cortical immune cells (microglia, green). Activated microgli

Updated on: April 16,2024

Alzheimer's research—intracellular calcium store malfunction leads to brain hyperactivity

by Universitaet TübingenAmyloid proteins (plaques, blue) in the cerebral cortex of a mouse model of Alzheimer’s disease, surrounded by cortical immune cells (microglia, green). Activated microgli

Updated on:April 16,2024

Dementia and COVID-19: Determinants of infection and mortality

by IOS PressFactors associated with 60-day mortality in dementia patients infected with SARS-CoV-2. Credit:Journal of Alzheimer's Disease(2022). DOI: 10.3233/JAD-220369The elderly

Updated on: May 06,2024

Dementia and COVID-19: Determinants of infection and mortality

by IOS PressFactors associated with 60-day mortality in dementia patients infected with SARS-CoV-2. Credit:Journal of Alzheimer's Disease(2022). DOI: 10.3233/JAD-220369The elderly

Updated on:May 06,2024

A 'low dose aspirin' for dementia? Drug ready for first in-human testing

by University of KentuckyLinda Van Eldik in her lab at the Sanders-Brown Center on Aging. Van Eldik's drug candidate, which might function as a sort of "low-dose aspirin" for the pr

Updated on: March 13,2024

A 'low dose aspirin' for dementia? Drug ready for first in-human testing

by University of KentuckyLinda Van Eldik in her lab at the Sanders-Brown Center on Aging. Van Eldik's drug candidate, which might function as a sort of "low-dose aspirin" for the pr

Updated on:March 13,2024

Multivariate analysis improves on cognitive testing in Alzheimer's disease

by Future Science GroupMultivariate analysis of cognitive tests in Alzheimer's disease identifies five distinct groups of Alzheimer's disease patients, and suggests that multivitamins might sl

Updated on: March 07,2024

Multivariate analysis improves on cognitive testing in Alzheimer's disease

by Future Science GroupMultivariate analysis of cognitive tests in Alzheimer's disease identifies five distinct groups of Alzheimer's disease patients, and suggests that multivitamins might sl

Updated on:March 07,2024

Prediction of conversion to Alzheimer's disease with longitudinal measures and time-to-event data

by IOS PressPredicting the timing of Alzheimer's disease (AD) conversion for individuals with mild cognitive impairment (MCI) can be significantly improved by incorporating longitudinal chang

Updated on: March 07,2024

Prediction of conversion to Alzheimer's disease with longitudinal measures and time-to-event data

by IOS PressPredicting the timing of Alzheimer's disease (AD) conversion for individuals with mild cognitive impairment (MCI) can be significantly improved by incorporating longitudinal chang

Updated on:March 07,2024

Schizophrenia linked to increased risk for subsequent CVD events

MARCH 1, 2024by Elana GotkineSchizophrenia is associated with an increased risk of subsequent cardiovascular disease (CVD) events, with the association stronger in women, according to a study publishe

Updated on: March 13,2024

Schizophrenia linked to increased risk for subsequent CVD events

MARCH 1, 2024by Elana GotkineSchizophrenia is associated with an increased risk of subsequent cardiovascular disease (CVD) events, with the association stronger in women, according to a study publishe

Updated on:March 13,2024

New blood test for Alzheimer's developed

by Margareta G. Kubista,University of GothenburgCredit: CC0 Public DomainA new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of

Updated on: April 18,2024

New blood test for Alzheimer's developed

by Margareta G. Kubista,University of GothenburgCredit: CC0 Public DomainA new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of

Updated on:April 18,2024